Key result
Obstructive HCM prevalence increased ~27% in a nationwide Japanese database from 2016 to 2020.
Why the study?
Limited data are available regarding therapies for hypertrophic cardiomyopathy.
Observational (n=25,627)
Yes
This nationwide Japanese database study highlights the increasing prevalence of hypertrophic cardiomyopathy, with a 1:5.2 ratio of obstructive to nonobstructive cases, and significant burdens of atrial fibrillation, stroke, and hospitalizations.
No takes yet. Share an insight, caveat, or question.
Rising HCM prevalence signals growing clinical caseloads with AF burden; extends prevalence estimates but leaves incidence vs detection open.
Terasaka et al. (2022) conducted an observational in Hypertrophic cardiomyopathy (HCM) (n=25,627). In a nationwide Japanese database from 2016 to 2020, the prevalence of obstructive and nonobstructive hypertrophic cardiomyopathy increased by 27% and 12%, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: